glp 1 coverage for weight loss GLP-1 NYC Who Gets the Shot? GLP-1

As discussed in greater detail earlier in this section, we believe it may be reasonable to consider a pathway to approve new products or products newly meeting the statutory requirements on a quarterly basis

More often than not, patients may need to try lower doses of the medication or an alternative class of GLP-1 agonists, as there is a variation in tolerability profile between them, says Criner

References 1.Zhu YS, Katz MD, Imperato-McGinley J

Surg Innov 24(6):616624

Growing demand, limited supply, and adverse effects such as gastrointestinal intolerance may further restrict their widespread adoption

J Clin Pharmacol 46(10):11791187 Steinert RE, Meyer-Gerspach AC, Beglinger C (2012) The role of the stomach in the control of appetite and the secretion of satiation peptides